JP2018512408A5 - - Google Patents

Download PDF

Info

Publication number
JP2018512408A5
JP2018512408A5 JP2017549107A JP2017549107A JP2018512408A5 JP 2018512408 A5 JP2018512408 A5 JP 2018512408A5 JP 2017549107 A JP2017549107 A JP 2017549107A JP 2017549107 A JP2017549107 A JP 2017549107A JP 2018512408 A5 JP2018512408 A5 JP 2018512408A5
Authority
JP
Japan
Prior art keywords
triazolo
pyridin
benzonitrile
cyano
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017549107A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018512408A (ja
JP6726681B2 (ja
Filing date
Publication date
Priority claimed from GBGB1504565.1A external-priority patent/GB201504565D0/en
Application filed filed Critical
Publication of JP2018512408A publication Critical patent/JP2018512408A/ja
Publication of JP2018512408A5 publication Critical patent/JP2018512408A5/ja
Application granted granted Critical
Publication of JP6726681B2 publication Critical patent/JP6726681B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017549107A 2015-03-18 2016-03-17 Phd阻害剤としての縮合二環式ヘテロアリール誘導体 Active JP6726681B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1504565.1A GB201504565D0 (en) 2015-03-18 2015-03-18 Novel compounds
GB1504565.1 2015-03-18
PCT/JP2016/059782 WO2016148306A1 (en) 2015-03-18 2016-03-17 Fused bicyclic heteroaryl derivatives having activity as phd inhibitors

Publications (3)

Publication Number Publication Date
JP2018512408A JP2018512408A (ja) 2018-05-17
JP2018512408A5 true JP2018512408A5 (enExample) 2019-04-25
JP6726681B2 JP6726681B2 (ja) 2020-07-22

Family

ID=53051992

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017549107A Active JP6726681B2 (ja) 2015-03-18 2016-03-17 Phd阻害剤としての縮合二環式ヘテロアリール誘導体

Country Status (31)

Country Link
US (1) US10287286B2 (enExample)
EP (1) EP3271357B1 (enExample)
JP (1) JP6726681B2 (enExample)
KR (1) KR102609431B1 (enExample)
CN (1) CN107531698B (enExample)
AU (1) AU2016234209B2 (enExample)
BR (1) BR112017019653B1 (enExample)
CA (1) CA2979024C (enExample)
CL (1) CL2017002354A1 (enExample)
CO (1) CO2017009353A2 (enExample)
CR (1) CR20170468A (enExample)
DK (1) DK3271357T3 (enExample)
DO (1) DOP2017000209A (enExample)
EA (1) EA035739B1 (enExample)
EC (1) ECSP17069696A (enExample)
ES (1) ES2774052T3 (enExample)
GB (1) GB201504565D0 (enExample)
GE (1) GEP20207095B (enExample)
HU (1) HUE047918T2 (enExample)
IL (1) IL254277B (enExample)
MX (1) MX2017011902A (enExample)
MY (1) MY194873A (enExample)
NZ (1) NZ735631A (enExample)
PE (1) PE20180656A1 (enExample)
PH (1) PH12017501699B1 (enExample)
PT (1) PT3271357T (enExample)
SG (1) SG11201707280VA (enExample)
TN (1) TN2017000384A1 (enExample)
UA (1) UA123668C2 (enExample)
WO (1) WO2016148306A1 (enExample)
ZA (1) ZA201706612B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2718902C2 (ru) 2016-02-24 2020-04-15 Пфайзер Инк. Производные пиразоло[1,5-а]пиразин-4-ила в качестве jak-ингибиторов
EP3668858A1 (en) 2017-08-14 2020-06-24 Pfizer Inc Pyrazolo[1,5-a]pyrazin-4-yl and related derivatives
DK3808747T3 (da) * 2018-09-13 2025-02-03 Kissei Pharmaceutical Imidazopyridinon-forbindelse
CN110950806A (zh) * 2019-11-14 2020-04-03 安庆博曼生物技术有限公司 四乙基氯化铵催化嘧啶环羟基氯代制备方法
JP7504822B2 (ja) * 2020-03-12 2024-06-24 キッセイ薬品工業株式会社 イミダゾピリジノン化合物を含む医薬組成物
US11718622B2 (en) 2020-03-16 2023-08-08 Exelixis Inc. Heterocyclic adenosine receptor antagonists
US20230322717A1 (en) * 2020-04-20 2023-10-12 Shenzhen Targetrx, Inc. Solid form of pyrazine substituted nicotinamide, and preparation and use thereof
JP7654071B2 (ja) * 2020-10-20 2025-03-31 アムジエン・インコーポレーテツド 複素環スピロ化合物及び使用方法
US12492178B2 (en) 2021-09-01 2025-12-09 Empathbio, Inc. Stable polymorph of R-MDMA HCl
IL312220A (en) 2021-10-28 2024-06-01 Insilico Medicine Ip Ltd Prolyl hydroxylase domain-containing protein (phd) inhibitors and uses thereof
JP2025500892A (ja) * 2021-12-17 2025-01-15 アケビア セラピューティクス インコーポレイテッド 選択的phd1阻害剤化合物、組成物、及び使用方法
US11912680B2 (en) 2021-12-28 2024-02-27 Empathbio, Inc. Nitric oxide releasing prodrugs of MDA and MDMA

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4209621A (en) 1979-04-27 1980-06-24 American Cyanamid Company (Substituted-phenyl)-1,2,4-triazolo[4,3-a]-pyrimidines and (substituted-phenyl)-1,2,4-triazolo[1,5-a]pyrimidines
DK135184A (da) * 1983-03-03 1984-10-10 Riker Laboratories Inc Triazol(4,3-c)- og triazol(1,5-c)pyrimidiner
US4572910A (en) * 1983-03-03 1986-02-25 Riker Laboratories, Inc. Triazolo[1,5-c]pyrimidines substituted by nitrogen-containing heterocyclic rings
JP2004502691A (ja) 2000-06-30 2004-01-29 ワイス 抗癌薬としての置換トリアゾロピリミジン
JP2010065026A (ja) 2008-08-13 2010-03-25 Ishihara Sangyo Kaisha Ltd ピリジル−トリアゾロピリミジン誘導体又はその塩、並びにそれらを含有する有害生物防除剤
JP2010065024A (ja) 2008-08-14 2010-03-25 Ishihara Sangyo Kaisha Ltd トリアゾロピリミジン誘導体又はその塩を含有する有害生物防除剤
HRP20140705T1 (hr) * 2009-07-17 2014-09-12 Japan Tobacco, Inc. Spoj triazolopiridina i njegovo djelovanje kao inhibitora prolil hidroksilaze i induktora proizvodnje eritropoetina
JP2011168582A (ja) * 2010-01-21 2011-09-01 Ishihara Sangyo Kaisha Ltd トリアゾロピリジン誘導体又はその塩、それらの製造方法及びそれらを含有する有害生物防除剤
US20150239889A1 (en) 2012-08-23 2015-08-27 Mitsubishi Tanabe Pharma Corporation Pyrazolopyrimidine compound

Similar Documents

Publication Publication Date Title
JP2018512408A5 (enExample)
JP2021502356A5 (enExample)
JP2010513283A (ja) 新規なオキサジアゾール化合物
RU2012104493A (ru) Замещенные соединения пиразоло [1,5-a] пиримидина как ингибиторы киназы trk
RU2016141645A (ru) ИНГИБИТОРЫ TrkA КИНАЗЫ, ОСНОВАННЫЕ НА НИХ КОМПОЗИЦИИ И СПОСОБЫ
RU2017116598A (ru) Соединения и композиции для модуляции киназной активности мутантов egfr
RU2013155456A (ru) Соединения пирролидинилмочевины и пирролидинилтиомочевины как ингибиторы киназы trka
JP2016517878A5 (enExample)
RU2017135520A (ru) Бициклические производные хиназолинона
RU2017121044A (ru) Производные амидотиадиазола в качестве ингибиторов надфн-оксидазы
JP2010510319A5 (enExample)
JP2019515931A5 (enExample)
JP2008516982A5 (enExample)
JP2019512482A5 (enExample)
RU2012143794A (ru) Производные n-(имидазопиримидин-7-ил)-гетероаламидов и их применение в качестве ингибиторов pde10a
GB2609879A (en) Antagonists of the adenosine A2a receptor
RU2015112580A (ru) Ингибиторные соединения
CA2610888A1 (en) Inhibitors of akt activity
HRP20140770T1 (hr) SUPSTITUIRANI SPOJEVI N-(1H-INDAZOL-4-IL)IMIDAZO[1,2-a]PIRIDIN-3-KARBOKSAMIDA KAO INHIBITORI CFMS
RU2006134021A (ru) Производные гетероарил-конденсированного пиразола
JP2017512794A5 (enExample)
RU2019132212A (ru) Селективные ингибиторы hdac6
JP2017508766A5 (enExample)
RU2011116232A (ru) Пиразолопиридиновые производные как ингибиторы надфн-оксидазы
RU2014150049A (ru) Ингибиторы nampt